Cargando…

Longitudinal changes in intracardiac repolarization lability in patients with implantable cardioverter-defibrillator

Background: While it is known that elevated baseline intracardiac repolarization lability is associated with the risk of fast ventricular tachycardia (FVT)/ventricular fibrillation (VF), the effect of its longitudinal changes on the risk of FVT/VF is unknown. Methods and Results: Near-field (NF) rig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guduru, Abhilash, Lansdown, Jason, Chernichenko, Daniil, Berger, Ronald D., Tereshchenko, Larisa G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3740232/ https://www.ncbi.nlm.nih.gov/pubmed/23964242 http://dx.doi.org/10.3389/fphys.2013.00208

Ejemplares similares

Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study
por: Haq, Kazi T., et al.
Publicado: (2021)

Delayed right ventricular perforation complicated by intracardiac thrombosis after implantable cardioverter‐defibrillator implantation
por: Ito, Tsuyoshi, et al.
Publicado: (2017)

Psychological factors and cardiac repolarization instability during anger in implantable cardioverter defibrillator patients
por: Krantz, David S., et al.
Publicado: (2021)

T Wave Amplitude Correction of QT Interval Variability for Improved Repolarization Lability Measurement
por: Schmidt, Martin, et al.
Publicado: (2016)

Understanding repolarization in the intracardiac unipolar electrogram: A long-lasting controversy revisited
por: Stoks, Job, et al.
Publicado: (2023)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Outcomes in Brugada Syndrome Patients With Implantable Cardioverter-Defibrillators: Insights From the SGLT2 Registry
por: Lee, Sharen, et al.
Publicado: (2020)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Reuse Potential of Pacemakers and Implantable Cardioverter-defibrillators - Some Real World Data
por: Abhilash, SP, et al.
Publicado: (2013)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Evaluation of a Fully Automatic Measurement of Short-Term Variability of Repolarization on Intracardiac Electrograms in the Chronic Atrioventricular Block Dog
por: Smoczyńska, Agnieszka, et al.
Publicado: (2020)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Intrapericardial Implantation of an Implantable Cardioverter-Defibrillator in a Child
por: Seong, Yong Won, et al.
Publicado: (2011)

Quality of Life in Patients with Implantable Cardioverter Defibrillators
por: Francis, Johnson, et al.
Publicado: (2006)

Perioperative Management of Patients with Implantable Cardioverter Defibrillators
por: Donnelly, Patrick, et al.
Publicado: (2007)

Electrical Storms in Patients with an Implantable Cardioverter Defibrillator
por: Song, Pil Sang, et al.
Publicado: (2011)

The use of implantable cardioverter defibrillators in pediatric patients
por: Campagnucci, V, et al.
Publicado: (2013)

The first cardioverter defibrillator implanted in Central Africa
por: Cabral, Tantchou Tchoumi Jacques, et al.
Publicado: (2016)

Implantable cardioverter-defibrillators in congenital heart disease
por: Chubb, H., et al.
Publicado: (2016)

Tachycardia detection in modern implantable cardioverter–defibrillators
por: Brüggemann, Thomas, et al.
Publicado: (2016)

Subcutaneous Implantable Cardioverter Defibrillator: Early Experience
por: Souza, Fernando Sérgio Oliva, et al.
Publicado: (2017)

Evolving use and indications for implantable cardioverter defibrillators
por: de Groot, J. R.
Publicado: (2018)

Wearable cardioverter defibrillator: Bridge or alternative to implantation?
por: Barraud, Jeremie, et al.
Publicado: (2017)

Implantable cardioverter defibrillators – the past, present and future
por: Ammannaya, Ganesh Kumar K.
Publicado: (2020)

Cost-Effectiveness of Cardioverter-Defibrillator Implantation in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

T-Wave Oversensing with Contemporary Implantable Cardioverter–Defibrillators
por: Strik, Marc, et al.
Publicado: (2023)

Implantable Cardioverter-Defibrillator for Primary Prevention in Asia
por: Younis, Arwa, et al.
Publicado: (2023)

Ventricular Repolarization Lability in Children With Kawasaki Disease
por: Kuriki, Marina, et al.
Publicado: (2011)

Higher defibrillation threshold in methamphetamine cardiomyopathy patients with implantable cardioverter-defibrillator
por: Malhotra, Rakesh, et al.
Publicado: (2017)

Implantable Cardioverter-Defibrillator in Dilated Cardiomyopathy after the DANISH-Trial Lesson. A Poly-Parametric Risk Evaluation Is Needed to Improve the Selection of Patients
por: Disertori, Marcello, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e7c3qu17rbnkuhiaiijcohirej